Hedge Fund - Propel Bio Management
Get Email AlertsLeen Kawas And Richard Kayne Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Propel Bio Management |
| Manager | Leen Kawas And Richard Kayne |
| Portfolio Value | $120,613,104 |
| Change This QTR | +99.00% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | PAGP | 1,372,360 | $21,889,142 | NEW | 18.14% | ||
| 2. | APLT | 5,374,982 | $18,006,190 | NEW | 14.92% | ||
| 3. | TCRX | 2,087,139 | $12,168,020 | NEW | 10.08% | ||
| 4. | Madrigal Pharmaceuticals Inc. | 30,032 | $6,948,804 | NEW | 5.76% | ||
| 5. | CRNX | 165,000 | $5,870,700 | NEW | 4.86% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-02-22 |
